Leerink Partners raised the price target for the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock to “an Outperform”. The rating was released on April 30, 2024, according to finviz. The research report …
More Lexicon Pharmaceuticals Inc (LXRX) Stock is more thoughtful than you think Videos